The significance of endothelial cell dysfunction in pulmonary microvessels in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
The significance of endothelial cell dysfunction in pulmonary microvessels in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
批准号:
17590778
负责人:
TAKABATAKE Noriaki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
在研究慢性阻塞性肺疾病(COPD)和特发性肺纤维化(IPF)中肺微血管内皮细胞功能障碍的意义之前,我们阐明了遗传多态性与COPD患者急性加重的关联。慢性阻塞性肺疾病(AECOPD)急性加重是慢性阻塞性肺疾病发病率和死亡率的主要原因。目的:宿主防御机制的显著异质性可能归因于炎症趋化因子基因的单核苷酸多态性(snp)在AECOPD气道中表达增强。方法:我们对276例男性COPD患者进行回顾性和前瞻性研究,研究了CCL11、CCL1和CCL5基因中与AECOPD发生频率和严重程度相关的4个snp。测量和主要结果:在为期两年的回顾性研究中,一个SNP (NCBI SNP参考:rs2282691)位于预测增强子区域,在显性模型中,CCL1基因编码一系列白细胞,包括单核细胞/巨噬细胞的趋化因子,与AECOPD的频率显著相关{Fisher精确检验[比值比(OR)(95%置信区间):2.70 (1.36-5.36),P=0.004], logistic回归[OR:3.06 (1.46 ~ 6.41), P=0.003], Kruskal-Wallis检验(P=0.003)。在30个月的前瞻性研究中,“A”等位基因是AECOPD严重程度的显著危险等位基因,基因剂量效应明显[Kaplan-Meier法log-rank检验;AA vs. TT;log-rank统计量:7.67,P=0.006。Cox比例风险回归法;或:5.93 (1.28-27.48),p =0.023]。电迁移转移实验表明,C/EBPβ是肺部感染应答的关键转录因子,它与T等位基因结合,而不是与a等位基因结合。结论:CCL1基因变异与AECOPD易感性相关,可能与宿主抗AECOPD防御机制的异质性有关。少
英文摘要
Prior to investigate the significance of endothelial cell dysfunction in pulmonary micro-vessels in chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), we elucidated the association of genetic polymorphisms with acute exacerbations in patients with COPD. Acute exacerbations in chronic obstructive pulmonary disease (AECOPD) are a major cause of morbidity and mortality in COPD. Objectives : The marked heterogeneity in the host defense mechanisms may be attributed to the single nucleotide polymorphisms (SNPs) in the inflammatory chemokine genes that show enhanced expressions in the airway of AECOPD. Methods : We have investigated four SNPs in CCL11, CCL1, and CCL5 genes with relation to the frequency and severity of AECOPD in the retrospective and prospective study of a cohort of 276 male patients with COPD. Measurements and Main Results : In the retrospective study for two years, one SNP (NCBI SNP reference : rs2282691) in the predicted enhancer region o … More f CCL1 gene, encoding a chemotactic factor for a series of leukocytes, including monocytes/macrophages, was significantly associated with the frequency of AECOPD in a dominant model {Fisher's exact test [odds ratio (OR) (95% confidence interval) : 2.70 (1.36-5.36), P=0.004], logistic regression [OR : 3.06 (1.46-6.41), P=0.003], and Kruskal-Wallis test (P=0.003)}. In the prospective study for 30 months, the 'A' allele was a significant risk allele for the severity of AECOPD with obvious gene dosage effect [Kaplan-Meier method with log-rank test ; AA vs. TT ; log-rank statistic : 7.67, P=0.006. Cox proportional hazards regression method ; OR : 5.93 (1.28-27.48), P=0.023]. The electromobility shift assay showed that C/EBPβ, a key transcriptional factor in response to pulmonary infections, binds to the 'T' allele, but not to the 'A' allele. Conclusions : Variants in CCL1 gene are associated with susceptibility to AECOPD through their potential implication in the heterogeneous features of the host defense mechanisms against AECOPD. Less
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Impaired systemic cell-mediated immunity and increased susceptibility to acute respiratorv tract infections in patients with COPD.
慢性阻塞性肺病患者全身细胞介导的免疫力受损,对急性呼吸道感染的易感性增加。
DOI:
--
发表时间:
2005
期刊:
Respir Med 99
影响因子:
--
作者:
[Numasaki M, Watanabe M, et al., Takabatake N.et al.]
通讯作者:
Takabatake N.et al.
Circulating levels of soluble Fas ligand in cachexic patients with COPD are higher than those in non-cachexic patients with COPD
恶病质 COPD 患者的可溶性 Fas 配体循环水平高于非恶病质 COPD 患者
DOI:
--
发表时间:
2005
期刊:
Intern Med. 44
影响因子:
--
作者:
[Inoue D, et. al., Takabatake N.et al.]
通讯作者:
Takabatake N.et al.
DOI:
10.1164/rccm.200603-443oc
发表时间:
2006-10-15
期刊:
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
影响因子:
24.7
作者:
[Takabatake, Noriaki, Shibata, Yoko, Kubota, Isao]
通讯作者:
Kubota, Isao
Research for the mechanism of the body weight loss in patients with chronic obstructive pulmonary disease
-
批准号:19590880
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:TAKABATAKE Noriaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
桔梗皂苷D驱动肠道菌群改善 IPF的整合作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
脐药灸调控Nrf2/GSH/GPX4通路抑制铁死亡促进IPF肺康复机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
清金通络汤通过抑制 SIRT3/SMAD3 介导的巨噬细胞-肌
成纤维细胞转化( MMT )治疗IPF 的研究
-
批准号:2024JJ6359
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吴趋荟
-
依托单位:
PRDX1/LTBP4/TGF-β轴介导的肺泡上皮细胞-巨噬细胞互
做抑制 MMT 在 IPF 进展的作用研究
-
批准号:2024JJ9483
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:周洁
-
依托单位:
基于 USP27X/Keap1/Nrf2 调控内质网应激减轻肺泡
上皮细胞衰老探讨麦门冬汤治疗 IPF 机制
-
批准号:2024JJ5236
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李仲普
-
依托单位:
FPR3+巨噬细胞高表达Fam20C调控肺间质干细胞分化参与IPF发生的分子机制探讨及疾病干预和预警的基础研究
-
批准号:82300085
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:侯继伟
-
依托单位:
CXCL13/ CXCR5信号通路通过调节LCK基因影响IPF患者肺移植术后BOS发生风险的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
补肺通络法介导IFN-γ/IL-4-JAKs/STATs途径分期调控AM极化及功能动态平衡防治IPF机制研究
-
批准号:82305157
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:张浩洋
-
依托单位:
基于仿生HDL药物载体调控mTORC2介导的肺部巨噬细胞炎症损伤在AE-IPF中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张苑
-
依托单位:
益气养阴活血通络法调控周细胞-内皮细胞Ang/Tie2信号恢复内皮生态位改善血管通透性治疗IPF机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:吕晓东
-
依托单位: